Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carnival Corp (CCL) vs Medtronic PLC (MDT) Price & Performance

Carnival CorpTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

Carnival Corp vs Medtronic PLC — how do they compare? Carnival Corp trades at $27.84 (market cap $37.98B), while Medtronic PLC trades at $90.74 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 3.1× Carnival Corp's market cap, and Medtronic PLC pays the higher dividend (3.18%). Which is the better fit depends on your goals.

CCLMDT
Market Cap
$37.98B$116.07B
Sector
Consumer CyclicalHealth
52-Week High
$33.99$105.35
52-Week Low
$23.89$73.75
Enterprise Value
$61.91B$134.82B
Dividend Yield
1.62%3.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carnival Corp

Carnival Corporation (CCL) trades at $27.82, showing modest daily gains of 0.25%. The stock maintains strong fundamental momentum with consecutive earnings beats in recent quarters (Q4 2025 and Q1 2026) and improving profitability trends. Technical indicators show a bearish bias in moving averages while oscillators remain neutral. The company demonstrates robust operational recovery with revenue growth from $12.2B in 2022 to $26.6B in 2025, and positive net cash flow of $727M in 2025 after years of negative cash flow.

CCL presents a compelling recovery story with analyst consensus pointing to 26% upside to the $35.18 price target. Investment opportunities include sustained travel demand, fleet expansion, and debt reduction progress. Key risks involve fuel price volatility, competitive pressures, and execution of growth initiatives amid economic uncertainty. The stock's attractive valuation (P/E 12.49x) and 59.6% analyst buy rating support a positive medium-term outlook.

Medtronic PLC

Medtronic (MDT) trades at $89.99, up 0.65% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with consistent earnings beats, 13.2% net income margin, and positive cash flow trends. Recent product innovations including the Hugo robotic surgery platform and AI surgical tools position MDT for growth. Analyst consensus remains strongly positive with 60% buy ratings and $98.75 price target.

MDT presents a compelling investment case with steady revenue growth, dividend aristocrat status, and technological leadership in medical devices. Key risks include increasing debt levels and competitive pressures from Intuitive Surgical. The stock's current valuation at 24.31 P/E appears reasonable given growth prospects, with upside potential to consensus targets if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Carnival Corp

Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.

Read more on CCL

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT